By usingin vitro models and an immunocompetent mouse model, we found that both propofol and sevoflurane lead to a reduction in CXCR4 expression and disruption of adhesion to thrombin-cleaved osteopontin in leukaemia cells. This evidence concerns the gene SPP1 and leukemia.